One of the more painful patterns in schizophrenia is the depression that often follows recovery from a psychotic episode — sometimes called post-psychotic depression. The voices have quieted. The delusions have faded. And just when life is supposed to feel manageable again, a heavy, low mood settles in. It is common, it is real, and it deserves to be treated as carefully as the psychosis was.
Depression occurs across the entire course of schizophrenia, is sometimes confused with negative symptoms or akinesia, and contributes substantially to suicide risk — but it can be treated with a thoughtful combination of medication and therapy.
How common is it?
Depressive symptoms are reported in roughly 25–50% of people with schizophrenia at any given time, and the lifetime prevalence is even higher. A 2017 review in Schizophrenia Research by Upthegrove and colleagues noted that depression occurs across all phases of the illness — prodrome, acute psychosis, post-psychotic period, and stable maintenance. The NIMH highlights that depression is a major contributor to suicide risk in schizophrenia, where lifetime suicide rates are around 5–10%.
What post-psychotic depression looks like
Typically appearing in the weeks to months after a psychotic episode resolves, post-psychotic depression often combines:
- Low mood that feels heavy, persistent, and qualitatively distinct from negative symptoms
- Hopelessness about the future and the diagnosis
- Grief — for lost time, lost roles, lost identity
- Shame or guilt about behaviour during the episode
- Suicidal thinking, which is particularly elevated in this period
It can be misread as success ("they're calmer now") or as negative symptoms ("they're just flat"). The distinguishing features are the cognitive content — guilt, hopelessness, loss of meaning — and the subjective experience of feeling sad rather than feeling absent.
There are thoughts of suicide, feelings of being a burden, giving away possessions, or making plans. The post-psychotic period is one of the highest-risk windows. Call 988 (US) or your local crisis line.
Distinguishing depression from negative symptoms
This is where many clinical decisions hinge. The picture often overlaps, but there are useful differentiators:
- Depression involves felt sadness, guilt, hopelessness, and pessimism. The person experiences distress and often longs to feel better.
- Negative symptoms involve a flatness or absence — reduced motivation, reduced emotional expression, reduced speech. The person doesn't typically describe feeling sad; they describe feeling nothing.
- Akinesia / parkinsonism from antipsychotics can mimic both — a slowed, unmoving presentation that looks depressed and feels exhausting.
What causes depression in schizophrenia?
- Biology: shared neurochemical and inflammatory pathways
- Insight: greater awareness of the diagnosis is associated with higher depression risk — knowing what one is dealing with is itself a heavy thing
- Loss: of relationships, jobs, education, plans
- Stigma: internalised stigma is one of the strongest predictors of depression in schizophrenia
- Medications: some antipsychotics (especially first-generation high-potency agents) can produce a flat, depressed-looking state
- Substance use: alcohol, cannabis, and stimulants all worsen mood
Treatment
1. Optimise the antipsychotic
If the antipsychotic itself seems to be contributing (e.g., heavy sedation, dysphoria, akinesia), the prescriber may consider a dose reduction or switch. Some second-generation agents — aripiprazole, lurasidone, brexpiprazole — have antidepressant-like effects and may be helpful in their own right.
2. Antidepressants
Adding an SSRI or SNRI to an antipsychotic for persistent depressive symptoms is well-supported. A 2017 meta-analysis in Schizophrenia Bulletin by Helfer and colleagues found modest but real benefit. Choice depends on the antipsychotic in use — fluoxetine and fluvoxamine raise clozapine and olanzapine levels significantly, so sertraline or escitalopram are often preferred.
3. Psychotherapy
CBT for psychosis (CBTp) includes work on depressive thinking. CBTp for negative symptoms overlaps. Behavioural activation — gradually rebuilding meaningful activity — is one of the most evidence-based depression interventions and translates well to schizophrenia.
4. Treating the loss
Post-psychotic depression often contains real grief about a real loss. Acknowledging that — rather than treating it purely as a chemical problem — is part of the work. Peer support groups help here in ways no medication can.
5. ECT for severe, treatment-resistant cases
Electroconvulsive therapy is occasionally used when depression is severe and unresponsive to other interventions, particularly when suicide risk is high. It is not a first-line treatment but remains an option in serious cases.
Suicide risk
Roughly 5–10% of people with schizophrenia die by suicide, and the highest-risk windows are the early years after diagnosis and the period immediately after a psychotic episode. Risk factors include:
- Recent hospital discharge
- Depression and hopelessness
- Insight into the diagnosis combined with poor support
- Substance use
- Command hallucinations to harm oneself
- Past suicide attempts
The single antipsychotic shown to reduce suicide risk in schizophrenia is clozapine, based on the InterSePT trial. For people with persistent suicidality, this is an important consideration.
What helps day-to-day
- Daily small structure — even one fixed activity per day
- Movement, even if minimal
- Sunlight and time outside
- Reducing alcohol, particularly important here
- Social contact, even if it feels effortful
- Tracking mood over time — patterns become visible that aren't obvious day-to-day
Apps like Frida can support that mood-tracking work, building a record that helps clinicians see the picture clearly.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.